Urethral recurrence in patients with orthotopic ileal neobladders

被引:152
作者
Freeman, JA
Tarter, TA
Esrig, D
Stein, JP
Elmajian, DA
Chen, SC
Groshen, S
Lieskovsky, G
Skinner, DG
机构
[1] UNIV SO CALIF,SCH MED,DEPT UROL,LOS ANGELES,CA 90033
[2] UNIV SO CALIF,SCH MED,DEPT PREVENT MED,LOS ANGELES,CA 90033
[3] UNIV SO CALIF,KENNETH NORRIS JR COMPREHENS CANC CTR,LOS ANGELES,CA 90033
关键词
urinary diversion; bladder; urethra; urethral neoplasms;
D O I
10.1016/S0022-5347(01)65462-4
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: We identified the risk of urethral recurrence following cystectomy for transitional cell bladder carcinoma, stratified by pathological characteristics of the bladder tumor and type of urinary diversion. Materials and Methods: The pathological characteristics and clinical courses of 174 men with a Kock ileal neobladder and 262 with a cutaneous urinary diversion were analyzed for time to urethral recurrence. Results: Urethral recurrence was identified in 34 patients at a median of 1.6 years after cystectomy, for an overall 7.9% 5-year risk of recurrence. Carcinoma in situ (p = 0.71) and multifocality (p = 0.17) did not independently confer an increased risk of recurrence. Prostatic urethral involvement, particularly stromal invasion, significantly increased the probability of recurrence (p < 0.001). Patients with a Kock ileal neobladder had a significantly lower probability of recurrence compared to those with cutaneous diversion (p = 0.015), even when associated with prostatic urethral involvement. Conclusions: Patients with a Kock ileal neobladder have a lower risk of urethral recurrence than those with cutaneous urinary diversion, even when associated with a high risk pathological condition predicting increased risk of urethral recurrence.
引用
收藏
页码:1615 / 1619
页数:5
相关论文
共 22 条
  • [1] ENTERIC ADENOMA AND ADENOCARCINOMA
    COOPER, MJ
    WILLIAMSON, RCN
    CHIR, M
    [J]. WORLD JOURNAL OF SURGERY, 1985, 9 (06) : 914 - 920
  • [2] Crocitto Laura E., 1994, Journal of Urology, V151, p379A
  • [3] MULTIDRUG RESISTANCE AND MUTAGENESIS
    FERGUSON, LR
    BAGULEY, BC
    [J]. MUTATION RESEARCH, 1993, 285 (01): : 79 - 90
  • [4] FREEMAN JA, 1994, UROL CLIN N AM, V21, P645
  • [5] ON THE USE OF CAUSE-SPECIFIC FAILURE AND CONDITIONAL FAILURE PROBABILITIES - EXAMPLES FROM CLINICAL ONCOLOGY DATA
    GAYNOR, JJ
    FEUER, EJ
    TAN, CC
    WU, DH
    LITTLE, CR
    STRAUS, DJ
    CLARKSON, BD
    BRENNAN, MF
    [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1993, 88 (422) : 400 - 409
  • [6] THE FUNCTION OF GP170, THE MULTIDRUG-RESISTANCE GENE-PRODUCT, IN THE BRUSH-BORDER OF RAT INTESTINAL-MUCOSA
    HSING, S
    GATMAITAN, Z
    ARIAS, IM
    [J]. GASTROENTEROLOGY, 1992, 102 (03) : 879 - 885
  • [7] SMALL INTESTINAL CYTOCHROMES-P450
    KAMINSKY, LS
    FASCO, MJ
    [J]. CRITICAL REVIEWS IN TOXICOLOGY, 1992, 21 (06) : 407 - 422
  • [8] KATO M, 1990, J JAP SURG SOC, V91, P851
  • [9] URINARY-DIVERSION VIA A CONTINENT ILEAL RESERVOIR - CLINICAL-RESULTS IN 12 PATIENTS
    KOCK, NG
    NILSON, AE
    NILSSON, LO
    NORLEN, LJ
    PHILIPSON, BM
    GOODWIN, WE
    [J]. JOURNAL OF UROLOGY, 1982, 128 (03) : 469 - 475
  • [10] LIESKOVSKY G, 1991, PROBL UROL, V5, P256